User:Mac: Difference between revisions
Jump to navigation
Jump to search
| Line 26: | Line 26: | ||
=== Academic Papers === | === Academic Papers === | ||
{{Cite journal | |||
| doi = 10.1038/nrd2033 | |||
| issn = 1474-1776 | |||
| volume = 5 | |||
| issue = 6 | |||
| pages = 463-469 | |||
| last = Phillips | |||
| first = Kathryn A. | |||
| coauthors = Stephanie Van Bebber, Amalia M. Issa | |||
| title = Diagnostics and biomarker development: priming the pipeline | |||
| journal = Nature Reviews Drug Discovery | |||
}} | |||
=== Market Reports === | === Market Reports === | ||
Revision as of 16:48, 26 August 2009
I am characterizing the R&D process that brings diagnostic kits to market with a particular focus on which steps involve patent (or other IP) activity.
I keep some notes in Evernote and then transfer them to the wiki. You can view my ICP evernote collection here
Here are all my contributions to the wiki.
current goals
Publish report about Commons-based activity in Diagnostic Kit Sector by end of September
- touch base on Monday w/ Carol
- work on skeleton of paper, meet to lay it out next Thursday (sept 3) morning
- re-read biotech section in april ICP report; discuss w/ Carol
Experts
- Jason Bobe
- Jason Kelly?
- Jim Hardy
- Andrew Hessel
- Joseph Jackson
- Mark Redmond (via LinkedIn)
Meeting Notes
References
Academic Papers
Market Reports
- Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development: http://www.reportbuyer.com/pharma_healthcare/drug_discovery/molecular_biomarkers_clinical_diagnostics_drug_discovery_development.html
- Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D: http://www.mindbranch.com/Biomarkers-Related-Tests-R183-014/
- Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success: http://www.the-infoshop.com/report/cd52985-pathways-rd_toc.html